glp-1 agonist and dpp-4 inhibitor What is the future of inhibitors? Medication like Sitagliptin, Linagliptin, Vildagliptin : 1. They will NOT disappear They still have a niche in: Elderly patients Frail patients CKD (especially Linagliptin – Dipeptidyl peptidase-4 enzyme in diabetes

Abstract Sulforaphane (SFN), an isothiocyanate derived from glucoraphanin in cruciferous vegetables, has evolved from a dietary antioxidant to a sophisticated multi-target agent in oncology

Because Each Child Is Unique Ask your doctor if INCRELEX is the appropriate treatment for your child INCRELEX (mecasermin) is used to treat children who are very short for their age because their bodies do not make enough insulin-like growth factor-1 (IGF-1)

L-Carnitine / L-Carnitine L-Carnitine (Mitochondria) L-Carnitine L-Carnitine L-Carnitine L-Carnitine (Lactic Acid) L-Carnitine L-Carnitine L-Carnitine L-Carnitine

Use of CDT-4 is limited to use in programs administered by the Centers for Medicare & Medicaid Services (CMS)

The DAPs from samples of T2 compared to T1 were listed in Additional file 2: Table S2